Uncategorized

Prem Premsrirut, M.D, PHD, President and CEO

SalivaClear is to Help People Across the Nation Return to School and Work with a Self-Collection Approach that is Noninvasive and Simple.

By Theresa on December 7, 2020 Diagnostics Tech, Uncategorized

Mirimus is the parent company of SalivaClear, a polymerase chain reaction (PCR) testing system with a focus on serving schools and workplaces. The goal of SalivaClear is to help people across the nation return to school and work with a self-collection approach that is noninvasive and simple. Prior to the outbreak of the coronavirus, Mirimus was heavily involved in genome editing technologies, especially in regards to the synergization of RNAi and CRISPR technologies. Mirimus is also considered a world leader in PCR testing, which is seen as the “gold standard” of Covid-19 testing. SalivaClear is centered around three main…

Henning Bundgaard

Danish Study of 4,860 Finds .03 Divergence in Mask vis No Mask

By VP Staff on November 25, 2020 Germ Security, Uncategorized

A newly released study in the academic journal Annals of Internal Medicine casts more doubt on policies that force healthy individuals to wear face coverings. To conduct the study, which ran from early April to early June, scientists at the University of Copenhagen recruited more than 6,000 participants who had tested negative for COVID-19 immediately prior to the experiment. Half the participants were given surgical masks and instructed to wear them outside the home; the other half were instructed to not wear a mask outside the home. Roughly 4,860 participants finished the experiment. 42 people in the mask group, or…

The Fluxergy Approach Makes Testing Portable and Consolidates All of the Various Processes into One Device

By Theresa on November 19, 2020 Diagnostics, Uncategorized

Fluxergy is a medical diagnostics company based in Irvine, California. The company was founded in 2003, and aims to answer the question: “Why is there not a better laboratory testing system on the market that can conduct a variety of tests at the point-of-use?” Over the years, Fluxergy has been developing a high-speed testing platform and an overall system that relies on state-of-the-art polymer chain reaction (PCR) and microfluids technology. The Fluxergy approach makes testing portable and consolidates all of the various processes into one device. This device is easy to use by clinicians in a laboratory setting, and it…

Stephen Chang, PhD Interview: Mirimus SalivaClear Test

By VP Staff on October 13, 2020 Member Roster, Uncategorized

Interview with Steven Chang PhD. Can you tell us about your current work? I’m currently involved in a company called Mirimus which has the saliva direct test, that’s licensed from Yale University. We do pool testing on virus on saliva samples for COVID. In people, children, especially because they’re just requires the ability to spit into a container. What is your background in the field of infectious disease? The pandemic that I’m most familiar with is the HIV. And testing was really, really critical, knowing who had the disease, who, how you could diagnose it. And so it became pretty…

Investment Network Forms to Advance COVID Technologies Rapid tests to be initial focus.

By VP Staff on September 24, 2020 Altru, Uncategorized

This Investment Network is an initiative of The Virus Project a platform for those working on solutions to the COVID crisis. The Investment Network will invest in the most promising solutions.

Download Report

Global Overview of COVID-19 Published. BALSA Report.

By VP Staff on September 16, 2020 library, Uncategorized

Global Overview of COVID-19 Testing. The Development of a Core Curriculum. The Virus Project commissioned a research report by BALSA a consulting enterprise operating from the Washington University in St. Louis. The report provides an overview of the scientific, regulatory and market issues for the COVID-19 testing in the United States. It is an exceptional resource for understanding the COVID testing marketplace. The report provides an over view of this new market that largely did not exist in January 2020 but could reach $20 billion in revenues in 2021. It would be the fastest market growth for a dead start…

Premiums

By VP Staff on September 15, 2020 Uncategorized

For its full members The Virus Project provides these two reports. A $750 Value. Foundational knowledge of COVID. US Report. Provides an overview of the scientific, regulatory and market issues for the COVID-19 testing market in the US and Europe. This market did not exist in January 2020 but could reach $20 billion in revenues in 2021. Growth Model on the potential size of the market and the various market segments. It includes an analysis of the impact on public stocks by COVID-19 during spring of 2020. Summary of core testing technologies. Molecular (PCR) tests and Serology IgM, IgA, IgG…

DecomBio Data Sheet

By VP Staff on August 30, 2020 Uncategorized

Browsing: Uncategorized